Indeed, transplantation of competent CCR2 hematopoietic stem cells is able to counteract amyloid pathology and to restore mnesic capacity in 6-month-old APPSwe/PS1 and APPSwe/PS1/CCR2−/− mice (Naert and Rivest, 2012). Here, CCR2 is linked to amyloidosis.